Litigation

Recent Posts

U.S. High Court Allows Solicitor General To Argue For Drug Design Defect Preemption
Posted on 4 Mar 2013 by Tom Moylan

WASHINGTON, D.C. - (Mealey's) The U.S. solicitor general will be allowed to argue March 19 that design defect claims involving generic drugs are preempted by federal law, the U.S. Supreme Court decided March 4 in granting the federal government's... Read More

U.S. High Court Won’t Decide ‘Clear Evidence’ In $63 Million Children’s Motrin Verdict
Posted on 19 Jan 2016 by Tom Moylan

WASHINGTON, D.C. — (Mealey's) The U.S. Supreme Court on Jan. 19 denied a petition by Johnson & Johnson and a subsidiary to decide if denial of a citizen petition constitutes “clear evidence” that the Food and Drug Administration... Read More

California State Jury Awards $48.1 Million In Motrin Injury Case
Posted on 4 Oct 2011 by Tom Moylan

LOS ANGELES - (Mealey's) A California state court jury on Oct. 3 awarded $48.1 million to a 22-year-old man who says Johnson & Johnson and subsidiary McNeil Consumer Healthcare failed to warn him that the nonprescription pain and fever remedy... Read More

Pennsylvania Appeals Court Affirms $10M Children’s Motrin TEN Injury Verdict
Posted on 23 Jul 2014 by Tom Moylan

PHILADELPHIA — (Mealey’s) A Pennsylvania appeals court panel on July 22 affirmed a $10 million Children’s Motrin verdict for a girl who suffered toxic epidermal necrolysis (TEN) after being given the over-the-counter pain/fever reducer... Read More